Cyber Monday saleUp to 70% OFF

Preearningsplay

Is FFIE running to earnings early ? Maybe yes. LONGFFIE is a penny stock of interest as it is also in the EV sector. Earnings are coming. In the past two days it jumped 82%. The stock is trading 99.9% ( no exaggeration ) down from its all-time high. On the 15-minute chart, price has jumped above its EMA cloud which inflected upward. A massive volume inflow peaked the price action in keeping with Wychoff's theory. 42 million shares traded yesterday morning. The EMA cloud settings are periods are 14/56/140 ( long story multiples of 7). The slow and fast RSI lines had a golden cross of fast over slow and both over the 50 are quite demonstrative of bullish momentum. ( settings 3 hrs and 1 week). I will play this long until earnings- adding 100 to 1000 shares per day at the low of the day on a 5-15 minute chart. I will also look at the options chain for March 15th. Given that WKHS did the same thing and reports the same time, something behind the stage curtains is underway. Penny stocks are always risky. My analysis has the risk diminished here.
NASDAQ:FFIELong
by AwesomeAvani
RTX a defense contractor large cap LONGRTX has earnings on April 23rd. It has been on a good trend higher since the last earnings. The Russian war means US defense contractors will be in a growth mode for the intermediate future. Depleted stores of weapons systems need to be replenished. Pieces and parts are needed for damaged systems in need of maintenance. I see RTX and others such as GD and LMT as good long-term trades or investments. Smaller companies in the areas of robotics and drones may be worth a look. RTX is at its all-time high but it seems much higher is in its future.
NYSE:RTXLong
by AwesomeAvani
1
OCGN pumps on dismissal of investor lawsuit LONGOCGN has been a great swing trade after buying bad news. The good news has replaced the bad. Earnings are in three days. Price well below ATH. November earnings were a beat meaning this risky Med Tech penny stock had a lower cash burn than projected. Now legal costs will disappear. Going long with a decent position expecting a better earnings. In law, the Latin phrase res ipsa loquitur is sometimes used. Here it aptly applies to Ocugen.
NASDAQ:OCGNLong
by AwesomeAvani
1
ORCL a preearnings SHORT TRADEORCL rose from its prior earnings which were not impressive. On the 180 minute chart, price ascended to the second upper anchored VWAP band and dropped to the mean VWAP band line in a standard Fibonacci retracement. Finally it turned upside and ascended to the first anchored VWAP line. The POC line of the immediate volume profile of the past two months is 113.9 and price is currently below it. RSI lines are near the 50 line and the green faster line is below the red slower line. The predictive modeling algo shows a forecasted regression line moving down on the approach to the earnings report after market close on March 11th. My target on this short trade is 101 being the pivot low at the prior earnings of December. This represents 10% downside. Accordingly, this is a one to three day trade covering the earnings period and after seeking 10% in quick profit. The stop loss is set at 114 above the near term POC line.
NYSE:ORCL
by AwesomeAvani
NVAX rises impending an earnings report LONGToday NVAX is selling for a tiny fraction of its all-time high as shown in a previous idea. Earnings is coming this upcoming week. This week NVAX news release showed it had settled a years long litigation over a failed COVID. In the face of earnings around the corner, was this news release a coincidence or instead a case of excellent executive and legal timing? I will skip the conspiracy discussion. On the chart, NVAX's bullish momentum is clear on its face. A price rise of 22% from a stock that has been stuck in deeply undervalued territory for a significant time period is remarkable. I have bought far out of the money call options into 2025 and 2026 some only this past month. Those from this month are now up over 250% with 11 and 23 months to go to expiration. I see NVAX as a risky penny medical stock with a high reward potential relative to the risk. It is a potential buy-out candidate and bankruptcy is less likely. The rich uncle is MRNA but the richer uncle in PFE might gain some interest. The wisest of capitalists buy out the competition when there is an opportunity and do not worry about the government crying monopoly when life-saving and life-extending medical products are involved. Time will tell. I expect insane profits.
NASDAQ:NVAX
by AwesomeAvani
Lemonade heads to earnings LONGLMND has upcoming earnings. On the 15 minute chart, price has gained 12% in the past two weeks. Typically, LMND beats estimates and experiences a surge from the earnings report. The chart shows a good trend up albeit with corrections along the way where the bears attempt to take a stand. This is an ascending channel with price currently in the middle of the channel's invisible histograms. The more shorts give up their positions and buy to cover, the further they contribute to the large trend. I will take a long position here for about a month through earnings. The potential profit that seems likely is well worth the risk on balance.
NYSE:LMND
by AwesomeAvani
2
FSR increasing volatility as earnings approach LONGFSR is on 15 minute chart. It has been in a down trend. However, as the earnings report due on Feburary 29th is near, trader interest has caused some buying volume spikes and upward price movement closing in a bull flag pattern after the squeeze indicator triggered several times and with the last a green histogram reflecting upward price action. The price-volume trend reversed bearish to bullish. I see this as a setup for a long trade of FSR into the earnings. In watching for an options setup I noted that the strike $0.50 same day expiration on 2/23 this past Friday went 0.03 to 0.12 nearly 375% while the same for 3/1 went 0.09 to 0.16 or about 75%. Al in all not matter shares or options, I see FSR as a set up for a long pre-earnings trade.
FLong
by AwesomeAvani
GRPN on a one month breakout LONGThis is to follow up my previous idea on Groupon. On the 2H chart, price is in a one month sustained breakout from the volume profile and into the upper VWAP band lines both anchored for end of 2023. The faster green RSI line crossed the 50 about the same time and basically has not looked down. The slower RSI line has slowly risen from 55 to 65. This is in the consumer discretionary sector and hot necessarily hinged to technology stocks. I see this as rock-solid as it gets. I will load more shares now and also load more ona dip There was a big earnings miss in November and then Goldman Sachs raised its target from 5 to 7.5 which seems like a big adjustment after an earnings miss. I suppose GS knows their stuff.
NASDAQ:GRPNLong
by AwesomeAvani
ROKU runs to Earnings ROKU on the 15- minute chart with an overlaid volume profile and anchored VWAP bands demonstrates a high volume area breakout on Tuesday last week having passed through the entire high volume area bottom to top the previous 24 hours. On those days it had a burst of volume. The volume is constant and consistent. Earnings are in two days. More volume spiking has been seen in the last trading session. I see this as an excellent long trade setup as a swing trade for the rest of the week into next if the earnings are better than they were last November
NASDAQ:ROKULong
by AwesomeAvani